104 related articles for article (PubMed ID: 38754514)
1. PKC-θ is an important driver of fluoride-induced immune imbalance of regulatory T cells/effector T cells.
Zhu S; Liu B; Fu G; Yang L; Wei D; Zhang L; Zhang Q; Gao Y; Sun D; Wei W
Sci Total Environ; 2024 Jul; 934():173081. PubMed ID: 38754514
[TBL] [Abstract][Full Text] [Related]
2. Phospho-flow cytometry based analysis of differences in T cell receptor signaling between regulatory T cells and CD4+ T cells.
Hanschen M; Tajima G; O'Leary F; Hoang K; Ikeda K; Lederer JA
J Immunol Methods; 2012 Feb; 376(1-2):1-12. PubMed ID: 21945004
[TBL] [Abstract][Full Text] [Related]
3. The vimentin intermediate filament network restrains regulatory T cell suppression of graft-versus-host disease.
McDonald-Hyman C; Muller JT; Loschi M; Thangavelu G; Saha A; Kumari S; Reichenbach DK; Smith MJ; Zhang G; Koehn BH; Lin J; Mitchell JS; Fife BT; Panoskaltsis-Mortari A; Feser CJ; Kirchmeier AK; Osborn MJ; Hippen KL; Kelekar A; Serody JS; Turka LA; Munn DH; Chi H; Neubert TA; Dustin ML; Blazar BR
J Clin Invest; 2018 Oct; 128(10):4604-4621. PubMed ID: 30106752
[TBL] [Abstract][Full Text] [Related]
4. Embryonic stem cell-derived factors inhibit T effector activation and induce T regulatory cells by suppressing PKC-θ activation.
Mohib K; AlKhamees B; Zein HS; Allan D; Wang L
PLoS One; 2012; 7(3):e32420. PubMed ID: 22412871
[TBL] [Abstract][Full Text] [Related]
5. The PI3K p110δ Isoform Inhibitor Idelalisib Preferentially Inhibits Human Regulatory T Cell Function.
Chellappa S; Kushekhar K; Munthe LA; Tjønnfjord GE; Aandahl EM; Okkenhaug K; Taskén K
J Immunol; 2019 Mar; 202(5):1397-1405. PubMed ID: 30692213
[TBL] [Abstract][Full Text] [Related]
6. PKC-Theta in Regulatory and Effector T-cell Functions.
Brezar V; Tu WJ; Seddiki N
Front Immunol; 2015; 6():530. PubMed ID: 26528291
[TBL] [Abstract][Full Text] [Related]
7. Ncf1 (p47phox) is essential for direct regulatory T cell mediated suppression of CD4+ effector T cells.
Efimova O; Szankasi P; Kelley TW
PLoS One; 2011 Jan; 6(1):e16013. PubMed ID: 21253614
[TBL] [Abstract][Full Text] [Related]
8. Abnormal effector and regulatory T cell subsets in paediatric-onset multiple sclerosis.
Mexhitaj I; Nyirenda MH; Li R; O'Mahony J; Rezk A; Rozenberg A; Moore CS; Johnson T; Sadovnick D; Collins DL; Arnold DL; Gran B; Yeh EA; Marrie RA; Banwell B; Bar-Or A
Brain; 2019 Mar; 142(3):617-632. PubMed ID: 30759186
[TBL] [Abstract][Full Text] [Related]
9. Human in vitro-induced regulatory T cells display Dlgh1dependent and PKC-θ restrained suppressive activity.
Zanin-Zhorov A; Kumari S; Hippen KL; Merkel SC; MacMillan ML; Blazar BR; Dustin ML
Sci Rep; 2017 Jun; 7(1):4258. PubMed ID: 28652577
[TBL] [Abstract][Full Text] [Related]
10. PKC-ѳ is dispensable for OX40L-induced TCR-independent Treg proliferation but contributes by enabling IL-2 production from effector T-cells.
Alharshawi K; Marinelarena A; Kumar P; El-Sayed O; Bhattacharya P; Sun Z; Epstein AL; Maker AV; Prabhakar BS
Sci Rep; 2017 Jul; 7(1):6594. PubMed ID: 28747670
[TBL] [Abstract][Full Text] [Related]
11. Protective Toxoplasma gondii-specific T-cell responses require T-cell-specific expression of protein kinase C-theta.
Nishanth G; Sakowicz-Burkiewicz M; Händel U; Kliche S; Wang X; Naumann M; Deckert M; Schlüter D
Infect Immun; 2010 Aug; 78(8):3454-64. PubMed ID: 20498263
[TBL] [Abstract][Full Text] [Related]
12. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase C-θ inhibits inducible regulatory T cell differentiation via an AKT-Foxo1/3a-dependent pathway.
Ma J; Ding Y; Fang X; Wang R; Sun Z
J Immunol; 2012 Jun; 188(11):5337-47. PubMed ID: 22539794
[TBL] [Abstract][Full Text] [Related]
14. PKC-θ function at the immunological synapse: prospects for therapeutic targeting.
Zanin-Zhorov A; Dustin ML; Blazar BR
Trends Immunol; 2011 Aug; 32(8):358-63. PubMed ID: 21733754
[TBL] [Abstract][Full Text] [Related]
15. Sex-specific differences in T-cell immune dysregulation and aberrant response to inflammatory stimuli in offspring exposed to maternal chronic inflammation.
Liu J; Liu Y; Kirschen G; Liu A; Lei J; Burd I
Am J Reprod Immunol; 2023 Mar; 89(3):e13665. PubMed ID: 36504421
[TBL] [Abstract][Full Text] [Related]
16. Differential requirement of PKC-theta in the development and function of natural regulatory T cells.
Gupta S; Manicassamy S; Vasu C; Kumar A; Shang W; Sun Z
Mol Immunol; 2008 Dec; 46(2):213-24. PubMed ID: 18842300
[TBL] [Abstract][Full Text] [Related]
17. Decreased LAG3 expression on T effector cells and regulatory T cells in SAA.
Sun Y; Liu C; Jiao T; Xie N; Wang H; Qi W; Shao Z
Int J Hematol; 2020 Dec; 112(6):757-763. PubMed ID: 32785818
[TBL] [Abstract][Full Text] [Related]
18. Tim-3 pathway controls regulatory and effector T cell balance during hepatitis C virus infection.
Moorman JP; Wang JM; Zhang Y; Ji XJ; Ma CJ; Wu XY; Jia ZS; Wang KS; Yao ZQ
J Immunol; 2012 Jul; 189(2):755-66. PubMed ID: 22706088
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C-theta participates in NF-kappaB activation induced by CD3-CD28 costimulation through selective activation of IkappaB kinase beta.
Lin X; O'Mahony A; Mu Y; Geleziunas R; Greene WC
Mol Cell Biol; 2000 Apr; 20(8):2933-40. PubMed ID: 10733597
[TBL] [Abstract][Full Text] [Related]
20. Adjuvants that improve the ratio of antigen-specific effector to regulatory T cells enhance tumor immunity.
Perret R; Sierro SR; Botelho NK; Corgnac S; Donda A; Romero P
Cancer Res; 2013 Nov; 73(22):6597-608. PubMed ID: 24048821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
